Cytological findings of ROS1-rearranged lung adenocarcinoma.

about

Cytological findings of ROS1-rearranged lung adenocarcinoma.

Item

http://www.wikidata.org/entity/Q47596157

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cytological findings of ROS1-rearranged lung adenocarcinoma.

@en

Cytological findings of ROS1-rearranged lung adenocarcinoma.

@nl

type

Item

label

Cytological findings of ROS1-rearranged lung adenocarcinoma.

@en

Cytological findings of ROS1-rearranged lung adenocarcinoma.

@nl

prefLabel

Cytological findings of ROS1-rearranged lung adenocarcinoma.

@en

Cytological findings of ROS1-rearranged lung adenocarcinoma.

@nl

P1476

Cytological findings of ROS1-rearranged lung adenocarcinoma

@en

P2093

Haruna Ide

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Tamiya

http://www.w3.org/2001/XMLSchema#string

Kaori Yasuoka

http://www.w3.org/2001/XMLSchema#string

Keiko Mizuno

http://www.w3.org/2001/XMLSchema#string

Kengo Takeuchi

http://www.w3.org/2001/XMLSchema#string

Kenji Yorita

http://www.w3.org/2001/XMLSchema#string

Kimiko Nakatani

http://www.w3.org/2001/XMLSchema#string

Masahiko Ohara

http://www.w3.org/2001/XMLSchema#string

Yukari Wada

http://www.w3.org/2001/XMLSchema#string

P2860

Testing for ROS1 in non-small cell lung cancer: a review with recommendations

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

RET, ROS1 and ALK fusions in lung cancer.

Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts.

Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer.

ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas.

Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma.

ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.

Anaplastic Lymphoma Kinase Immunocytochemistry on Cell-Transferred Cytologic Smears of Lung Adenocarcinoma.

P304

336-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DC.23845

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Naoto Kuroda

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29076659

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma